Efficacy and Safety ofSanGrow Decoction for Patients With Diabetes

Shidaihuajing Institute for Diabetic Research

Status

Unknown

Conditions

Diabetes Mellitus

Treatments

Dietary Supplement: SanGrow Decoction

Study type

Interventional

Funder types

Other

Identifiers

NCT02660593

SanGrow Decoction for diabetes

Details and patient eligibility

About

MedlinePlus related topics: Blood Sugar

Primary Outcome Measures:

Fast glucose and HbA1c change between the baseline and end of study [ Time Frame: From baseline to 30 and 100 days]
[ Designated as safety issue: No ]
Successful rate of blood glucose control (the proportion of patients with HbA1c <7%) [ Time Frame: From baseline to 30 days and 100 days] [ Designated as safety issue: No ]

Secondary Outcome Measures:

• To evaluate the change of quality of life in the 1 months by the health questionnaire SF-36 [ Time Frame: From baseline to month 1 ] [ Designated as safety issue: No ]

Full description

This study is aimed to evaluate the safety and efficacy of Sangrow Decotion, diet and exercise for the treatment of type 2 diabetes. Previous study has shown that this therapeutic regimen is safe and effective.

Enrollment

20 estimated patients

Sex

All

Ages

10 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Type II diabetes mellitus patients who have received medical treatment for more than 3 months
Patients willing to sign written informed consent form

Exclusion criteria

Patients unable or unwilling to comply with the requirements of the protocol
Females who are pregnant or nursing or females of childbearing potential who are unwilling to maintain contraceptive therapy for the duration of the study
Life expectancy < 6 months due to concomitant illnesses.